Similar articles

• Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.

  Bialas T, Kolitz J, Levi E, Polivka A, Oez S, Miller G, Welte K. Bialas T, et al. Cancer Res. 1988 Feb 15;48(4):891-8. Cancer Res. 1988. PMID: 3257413
• TNF as immunomodulatory agent.

  Bonavida B. Bonavida B. Immunol Ser. 1992;56:315-29. Immunol Ser. 1992. PMID: 1550866 Review. No abstract available.
• [Tumor necrosis factor and AIDS--the mechanism of development of AIDS].

  Kobayashi N. Kobayashi N. Tanpakushitsu Kakusan Koso. 1989 Nov;34(14):1904-10. Tanpakushitsu Kakusan Koso. 1989. PMID: 2594987 Japanese. No abstract available.
• Re-evaluation of the chemotactic activity of tumour necrosis factor for monocytes.

  Wang JM, Walter S, Mantovani A. Wang JM, et al. Immunology. 1990 Nov;71(3):364-7. Immunology. 1990. PMID: 2269474 Free PMC article.
• Lymphotoxin and tumour necrosis factor as possible mediators of an inflammatory response.

  [No authors listed] [No authors listed] Ciba Found Symp. 1987;131:185-91. Ciba Found Symp. 1987. PMID: 3330010 Review. No abstract available.